India’s Serum Institute Invests in IntegriMedical of Indiana

Pune-based Serum Institute of India (SII) announced a strategic investment in IntegriMedical, based in Bainbridge, IN. where SII will acquire a 20% stake in the company. This partnership aims to advance IntegriMedical’s Needle-Free Injection System (N-FIS) technology, aligning with SII’s vision of ‘Health for All’ and IntegriMedical’s mission to ‘Transform Healthcare Globally.”

 

N-FIS utilizes a high-velocity jet stream powered by mechanical force to effectively and consistently administer biologics and liquid medications without needles. This needle-free drug delivery solution seeks to alleviate pain during administration, providing needle-phobic patients with a more pleasant and stress-free experience while enhancing medication efficacy through needle-free dispersion.

 

Read more@ https://amritt.com/the-india-expert-blog/indias-serum-institute-invests-in-integrimedical-of-indiana/

Comments

Popular posts from this blog

Intramuscular Injections

Intramuscular Injections: The Future of Pain-Free Vaccinations

Subcutaneous Injections